EU Medicines Agency @EMA_News@respublicae.eu

Re If animal owners or #farmers ask for more information on #antibiotics, what sources do you guide them towards?

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671125011946520577

Re How do you keep updated on antimicrobial resistance #AMR?

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671125014375018496

Re How much do you trust healthcare professionals’ advice about using #antibiotics?

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671183688489369600

Re Do you think or worry about antimicrobial resistance (#AMR) when using #antibiotics?

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671183691047903235

Re @AGE_PlatformEU, @cancereu, @beuc, @ehnheart, @EuropeanLung, @eurordis, @eupatientsforum, @EPHA_EU, @HAImedicines, @EFA_Patients, @AlzheimerEurope

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671184615912947718

#DYK that EMA has a dedicated office to address the specific needs of small companies? 🏢💊
By providing regulatory advice and training, we support SMEs that develop innovative medicines.
Find out more in the #SME office annual report 2022
➡️https://www.ema.europa.eu/en/documents/report/small-medium-sized-enterprise-sme-office-annual-report-2022_en.pdf https://t.co/uBMjW8Kwwr

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671493310882430976

📢Just published! Read a new report how the EU medicines network collected, analysed and assessed safety data generated during the COVID-19 vaccination campaigns.
👉https://www.ema.europa.eu/en/news/report-how-eu-ensured-safety-medicines-during-covid-19
#COVID19 #vaccines https://t.co/tX8LEDoFGG

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671819838149230592

📣 Calling all EU-based high-risk #MedicalDevice manufacturers: apply by 15 Sep 2023 to join Phase 2 of EMA's scientific advice pilot.
Prioritised devices include:
🩹 devices for rare conditions
⚕️ devices addressing unmet needs
🩺 novel devices with a major clinical impact

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671886724962852871

What experience have we gained so far in conducting studies with real-world data to support EMA's regulatory decision making? 📊📉⚕️
Check out our new report to find out ⬇️ https://www.ema.europa.eu/en/news/use-real-world-evidence-regulatory-decision-making-ema-publishes-review-its-studies
#RealWorldData #BigData https://t.co/KBdAmqQwGh

🐦🔗: https://n.respublicae.eu/EMA_News/status/1672243938336428032

RT @SKyriakidesEU: I warmly welcome the adoption of our Recommendation on #AMR by #EPSCO Council, only two months after it was proposed.

We are taking decisive action in record time to tackle a growing health threat.

This is a strong #HealthUnion in action. https://t.co/HIurpO4xBx

🐦🔗: https://n.respublicae.eu/EMA_News/status/1668536557156937733

RT @SandraGallina: There is no health without #MentalHealth

Our new comprehensive approach to mental health from last week includes a flagship initiative aiming for more & better trained professionals across the EU.

Join our call for tenders by 4 September:
https://hadea.ec.europa.eu/news/eu4health-call-tenders-mental-health-training-and-exchange-programmes-health-professionals-2023-06-12_en

#HealthUnion

🐦🔗: https://n.respublicae.eu/EMA_News/status/1668536482687070208

RT @EC_HERA: Clinical trials are the cornerstone to generate reliable info on the use of safe and effective medicines. Swift & coordinated response of clinical research to health threats is essential.

HERA presents at the lessons-learned workshop on Clinical Trials in Health Emergencies. https://t.co/RpvfAy7PDx

🐦🔗: https://n.respublicae.eu/EMA_News/status/1668230453097054216